Voloridge Investment Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-248,610
| Closed | -$1.03M | – | 1601 |
|
|
2022
Q2 | $1.03M | Sell |
248,610
-84,472
| -25% | -$350K | 0.01% | 1184 |
|
|
2022
Q1 | $1.94M | Buy |
+333,082
| New | +$1.94M | 0.01% | 963 |
|
|
2021
Q1 | – | Sell |
-588,624
| Closed | -$9.19M | – | 1629 |
|
|
2020
Q4 | $9.19M | Buy |
+588,624
| New | +$9.19M | 0.08% | 288 |
|
|
2020
Q3 | – | Sell |
-38,454
| Closed | -$345K | – | 1476 |
|
|
2020
Q2 | $345K | Buy |
+38,454
| New | +$345K | ﹤0.01% | 1108 |
|
|
2019
Q2 | – | Sell |
-10,190
| Closed | -$97K | – | 1033 |
|
|
2019
Q1 | $97K | Buy |
+10,190
| New | +$97K | ﹤0.01% | 909 |
|
|
2018
Q2 | – | Sell |
-98,244
| Closed | -$1.87M | – | 584 |
|
|
2018
Q1 | $1.87M | Sell |
98,244
-109,189
| -53% | -$2.07M | 0.04% | 289 |
|
|
2017
Q4 | $3.4M | Buy |
+207,433
| New | +$3.4M | 0.07% | 256 |
|